Delivery Order SPE2DB22D1017-SPE2DB25FG4LV

Award Date 6/6/25
Potential Completion Date 6/30/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of Bosulif 400 mg tablets, a specialty medication, at a firm fixed price of $21,910.86. The award is not associated with a set-aside program and has an ultimate completion date of September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,047.42, is to deliver 120 units of the prescription drug BOSULIF 100 mg tablets. The award has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bosulif 400 mg tablets. The $23,631.26 firm-fixed-price contract has a completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $21,910.86 firm fixed-price delivery order is for Bosulif 400 mg tablets and has a completion date of July 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,815.63, is for the supply of 4,567,965,360 units of the prescription medication Bosulif 400 mg tablet, with a completion date of May 9, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the provision of 120 tablets of the medication BOSULIF 100 MG. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Bosulif (400 mg tablet, 30 count) at a ceiling value of $10,955.43. The award has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This federal contract award, valued at $5,704.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,059,457 units of the prescription medication BOSULIF 100 MG TABLET 120S. The contract is a firm fixed-price, non-set-aside award with a completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $5,339.18, is for the delivery of 120-count tablets of the prescription medication Bosulif (100 mg). The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of pharmaceutical and medical supplies in support of...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,678.36 firm fixed-price delivery order is for the supply of BOSULIF 100 MG TABLET 120S, with an ultimate completion date of November 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG4LV
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,815.63 contract is for the delivery of Bosulif 400 mg tablets, a prescription medication. The award has a performance period ending on June 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order is not designated as a set-aside contract.

Generated 9/5/25, 9:56 AM